date,title,source
Oct-17-18,Krystal Biotech Announces Commencement of $60.0 Million Public Offering of Common Stock,GlobeNewswire
Oct-18-18,Krystal Biotech Announces Pricing of $60.0 Million Public Offering of Common Stock,GlobeNewswire
Oct-22-18,"Krystal Biotech Inc (KRYS) President and CEO Krish S Krishnan Bought $500,000 of Shares",GuruFocus.com
Oct-22-18,Chardan Serves as Lead Manager for Krystal Biotech,PR Newswire
Oct-23-18,Krystal Biotech Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters Over-Allotment Option,GlobeNewswire
Nov-05-18,Krystal Biotech Reports Third Quarter 2018 Financial Results and Provides Corporate Update,GlobeNewswire
